Study shows liraglutide results in increased insulin sensitivity independent of weight loss
A new study demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity, can lead to a rapid improvement in insulin sensitivity.
https://www.sciencedaily.com/releases/2024/01/240104210206.htm